Amphastar Pharmaceuticals, Inc.
AMPH
$27.10
-$0.48-1.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 111.63M | 134.71M | 141.63M | 159.52M | 157.72M |
| Total Depreciation and Amortization | 61.88M | 60.54M | 58.45M | 57.21M | 56.33M |
| Total Amortization of Deferred Charges | 3.21M | 3.07M | 4.67M | 6.03M | 8.22M |
| Total Other Non-Cash Items | 7.39M | 12.49M | 12.43M | 5.18M | 18.66M |
| Change in Net Operating Assets | -31.83M | -51.16M | -24.00M | -14.55M | -32.70M |
| Cash from Operations | 152.28M | 159.66M | 193.17M | 213.39M | 208.23M |
| Capital Expenditure | -39.02M | -47.47M | -42.95M | -41.04M | -38.07M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | -129.00M | -129.00M | -129.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.42M | -12.94M | 42.26M | 45.11M | -25.23M |
| Cash from Investing | -45.44M | -60.41M | -129.69M | -124.93M | -192.30M |
| Total Debt Issued | 10.81M | 20.15M | 15.99M | 18.43M | 13.57M |
| Total Debt Repaid | -234.00K | -231.00K | -8.20M | -8.26M | -58.30M |
| Issuance of Common Stock | 873.00K | 494.00K | -- | -- | 3.56M |
| Repurchase of Common Stock | -93.69M | -120.53M | -88.68M | -90.31M | -51.69M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -657.00K | -1.24M | -986.00K | -816.00K | -1.33M |
| Cash from Financing | -82.89M | -101.36M | -81.88M | -80.95M | -94.19M |
| Foreign Exchange rate Adjustments | 208.00K | 186.00K | 25.00K | -190.00K | -417.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 24.15M | -1.93M | -18.37M | 7.31M | -78.69M |